首页> 外文OA文献 >Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

【2h】

Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

机译：达贝泊汀阿尔法和重组人促红细胞生成素治疗接受腹膜透析的慢性肾衰竭患者肾性贫血的随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Li Wen-Yi; Chu Tzong-Shinn; Huang Jenq-Wen; Wu Ming-Shiou; Wu Kwan-Dun;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Darbepoetin Alfa Versus Erythropoietin Alfa for Treatment of Renal Anemia in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage: A Randomized Non-inferiority Trial [J] . Mehta KS, Sinha SD, Bandi Vamsi, Journal of the Association of Physicians of India . 2019,第1期

机译：Darbepoetin Alfa与促红细胞生成素Alfa治疗患有慢性肾脏疾病术前阶段的慢性肾病患者：随机的非劣级试验
2. Conversion from Recombinant Human Erythropoietin to Once Every 4 Weeks Darbepoetin Alfa for Treatment of Renal Anemia in CAPD Patients [J] . Hong Kong Journal of Nephrology . 2007,第2期

机译：从重组人促红细胞生成素转换为每4周一次达比泊汀阿尔法治疗CAPD患者的肾性贫血
3. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients [J] . Yves Vanrenterghem, Peter Bárány, Johannes F E Mann, Kidney international. . 2002,第6期

机译：相对于rHuEPO，达比泊汀α降低剂量频率治疗肾性贫血的随机试验
4. Peritoneal Dialysis for Management of Patients with Chronic Heart Failure and Cardiorenal Syndrome [C] . Kazory A. World Congress on Heart Disease. . 2013

机译：腹膜透析治疗慢性心力衰竭和心肺综合征的患者
5. Studies on copper metalloprotein concentrations in humans with end stage renal disease receiving maintenance hemodialysis or continuous ambulatory peritoneal dialysis [D] . Emenaker, Nancy Jean. 1994

机译：维持性血液透析或连续非卧床腹膜透析的终末期肾脏病患者铜金属蛋白浓度的研究
6. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb 27-week multicenter open-label study in Greek patients [O] . Georgios Bristoyiannis, Nikolaos Germanos, Dimitrios Grekas, 2005

机译：从重组人促红细胞生成素转换为晚期肾病患者贫血治疗中达比泊汀α的单位剂量：一项针对希腊患者的27b周多中心开放性研究的IIIb期研究结果
7. Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis [O] . Wen-Yi Li, Tzong-Shinn Chu, Jenq-Wen Huang, 2008

机译：Darbepoetin alfa和重组人促红细胞生成素治疗慢性肾功能衰竭腹膜透析患者肾性贫血的随机研究

Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

著录项

相似文献

相关主题

期刊订阅